lamivudine has been researched along with brl 42810 in 99 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 27 (27.27) | 18.2507 |
2000's | 66 (66.67) | 29.6817 |
2010's | 5 (5.05) | 24.3611 |
2020's | 1 (1.01) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Asif, G; Butler, SD; Chu, CK; Cote, PJ; George, AL; Gerin, JL; Hurwitz, SJ; Menne, S; Narayanasamy, J; Schinazi, RF; Tennant, BC | 1 |
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Beadle, JR; Bradley, M; Farasati, NA; Hostetler, KY; Huang, Y; Meier, C; Randhawa, P; Sauerbrei, A; Zemlicka, J | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
de Man, RA; Heijtink, RA; Niesters, HG; Schalm, SW | 2 |
Terrault, NA; Wright, TL | 1 |
Perrillo, RP | 3 |
Melegari, M; Scaglioni, PP; Wands, JR | 1 |
Bain, VG; Davis, JE; Erb, SR; Fischer, KP; Kneteman, NM; Ma, MM; Tyrrell, DL; Yoshida, EM | 1 |
Arnold, JC; Golling, M; Herfarth, C; Otto, G; Rudek, B; Theilmann, L | 1 |
Tassopoulos, NC | 1 |
Córdoba Cortijo, J; López Viedma, B; Olaso Peiró, V | 1 |
de Man, RA; Honkoop, P; Niesters, HG; Wolters, LM | 1 |
Jaeckel, E; Manns, MP | 1 |
Mutimer, D | 1 |
Bartholomeusz, AI; de Man, RA; Locarnini, SA; Niesters, HG; Zondervan, PE | 1 |
Lavanchy, D; Renner, EL | 1 |
Main, J; McCarron, B; Thomas, HC | 1 |
Carman, WF; Lam, SK; Lau, GK; Locarnini, SA; Lu, ZM; Okuda, K; Williams, R | 1 |
Kumashiro, R; Sata, M | 1 |
Bock, T; Böker, KH; Bruns, I; Condreay, LD; Gauthier, J; Glowienka, M; Jäckel, E; Manns, MP; Oldhafer, K; Raab, HR; Tillmann, HL; Trautwein, C | 1 |
Cane, PA; Mutimer, D; Pillay, D | 1 |
Bechstein, WO; Budde, K; Hocher, B; Krüger, DH; Meisel, H; Neuhaus, P; Neumayer, HH; Preikschat, P; Reinke, P | 1 |
Trepo, C; Zoulim, F | 1 |
Hultgren, C; Milich, DR; Sällberg, M; Weiland, O | 1 |
Keating, MR | 1 |
Locarnini, SA; Shaw, T | 1 |
Cane, PA; Cook, P; Dowling, D; Elias, E; Mutimer, D; O'Donnell, K; Pillay, D; Ratcliffe, D; Shaw, J | 1 |
Berby, F; Petit, MA; Pichoud, C; Stuyver, L; Trépo, C; Zoulim, F | 1 |
Freiman, JS; McCaughan, GW | 1 |
Cote, P; Gerin, JL; Hornbuckle, W; Korba, BE; Schinazi, R; Tennant, BC | 1 |
Airoldi, A; Pinzello, G; Zavaglia, C | 1 |
Fen, X; Hou, J; Nie, Z | 1 |
Kruger, M; Lake, JR; Perrillo, RP; Sievers, T | 1 |
Carman, WF; Gibbs, CS; Hou, J; Lam, S; Lau, GK; Tsiang, M; Yuen, S; Zhang, L | 1 |
Locarnini, S; Shaw, T | 1 |
Leung, N | 1 |
Bechstein, WO; Berg, T; Hopf, U; Müller, AR; Neuhaus, P; Neuhaus, R; Rayes, N; Seehofer, D | 1 |
Abidi, H; Ahmed, S; Berby, F; Johnson, M; Merle, P; Nafa, S; Pichoud, C; Stuyver, L; Tavan, D; Trépo, C; Zoulim, F | 1 |
Bechstein, WO; Berg, T; Hopf, U; Langrehr, JM; Müller, AR; Naumann, U; Neuhaus, P; Neuhaus, R; Platz, KP; Rayes, N; Seehofer, D; Steinmüller, T | 1 |
Bechstein, WO; Berg, T; Müller, AR; Neuhaus, P; Neuhaus, R; Rayes, N; Seehofer, D | 1 |
Fischer, L; Rogiers, X; Sterneck, M; Zöllner, B | 1 |
Bechstein, WO; Hopf, U; Naumann, U; Neuhaus, P; Neuhaus, R; Rayes, N; Seehofer, D | 1 |
Grande Santamaría, L; Romero Gómez, M; Suárez García, E | 1 |
Forns, X; Sánchez-Tapias, JM | 1 |
Fried, MW; Sommadossi, JP | 1 |
Bock, CT; Colledge, D; Delaney, WE; Edwards, R; Isom, HC; Locarnini, S; Manns, MP; Miller, TG; Shaw, T; Torresi, J; Trautwein, C | 1 |
Lau, GK | 1 |
Cahlin, C; Friman, S; Olausson, M | 1 |
Delaney, WE; Locarnini, S; Shaw, T | 1 |
Bar-Nathan, N; Ben-Ari, Z; Dinari, G; Mor, E; Shapira, R; Sokal, EM; Tur-Kaspa, R | 1 |
Chen, Y; Guo, S; Huang, A; Qi, Z | 1 |
Bowden, S; Lau, GK; Lewin, SR; Locarnini, S; Perelson, AS; Ribeiro, RM; Walters, T | 1 |
Bechstein, WO; Berg, T; Müller, AR; Naumann, U; Neuhaus, P; Neuhaus, R; Rayes, N; Seehofer, D; Steinmüller, T; Tullius, SG | 1 |
Cane, P; Gazzard, B; Matthews, GV; Nelson, M; Pillay, D; Ratcliffe, D | 1 |
de Man, RA; Niesters, HG; Wolters, LM | 1 |
Chan, TM; Ho, SK; Lai, KN; Moniri, K; Tang, S | 1 |
Duan, Y; Liang, S; Wang, F; Yuan, G; Zhu, L | 1 |
Di Bisceglie, AM | 1 |
Ben-Ari, Z; Daudi, N; Dinari, G; Klein, A; Mor, E; Shapira, R; Shouval, D; Tur-Kaspa, R | 1 |
Nguyen, MH; Wright, TL | 1 |
Aulitzky, WE; Einsele, H; Henkes, M; Martin, S | 1 |
Cheng, CT; Garrido-Lestache, S; Hui, CK; Lai, CL; Lai, YP; Yuen, MF | 1 |
Colak, H; Demirtürk, N; Dinçer, S; Kartal, ED; Ozgünes, I; Usluer, G | 1 |
Dimou, E; Papadimitropoulos, V; Papatheodoridis, GV | 1 |
Hollander, A; Lindh, G; Sangfelt, P; Uhnoo, I; Weiland, O | 1 |
Guan, R; Kajiji, T; Lim, SG; Rajnakova, A; Wai, CT | 1 |
Fischer, L; Meier, D; Rogiers, X; Sterneck, M; Zöllner, B | 1 |
de Man, RA; Hansen, BE; Niesters, HG; Wolters, LM | 1 |
Terrault, NA | 1 |
Ji, D; Li, L; Shao, Q; Zhang, J | 1 |
Ayres, A; Bartholomeusz, A; Lam, KC; Lau, G; Lee, JY; Locarnini, S | 1 |
Ji, W; Li, L; Su, HB; Wang, HF | 1 |
Ozden, N; Saruc, M; Yuceyar, H | 1 |
Lagget, M; Rizzetto, M | 1 |
Arnold, E; Das, K; Delaney, WE; Gibbs, CS; Miller, MD; Westland, CE; Xiong, S; Yang, H | 1 |
Huang, DS; Liang, TB; Wang, WL; Wu, J; Xu, X; Zheng, SS | 1 |
Berenguer, M; Wright, TL | 1 |
Echevarría, JM; León, P; Pozo, F | 1 |
Alsatie, M; Chalasani, N; Eckert, G; Kwo, PY; Lumeng, L; Shen, H | 1 |
Berr, F; Etzrodt, G; Klecker, C; Liebert, UG; Maier, M; Oesen, U; Schiefke, I; Tannapfel, A | 1 |
Avci, A; Erhardt, A; Häussinger, D; Heintges, T; Lörke, J; Sagir, A | 1 |
Acar, K; Aki, Z; Bozdayi, G; Haznedar, R; Sucak, GT; Yağci, M | 1 |
Bara, C; Böker, KH; Deterding, K; Haverich, A; Manns, MP; Meyer, S; Pethig, K; Potthoff, A; Tillmann, HL; Wedemeyer, H | 1 |
Angelousi, AG; Charatsis, GG; Falagas, ME; Lampropoulos, KM; Panos, GZ | 1 |
Bock, CT; Finger, A; Heidrich, B; Manns, MP; Michel, G; Rosenau, J; Tillmann, HL; Wedemeyer, H; Wiegand, J | 1 |
28 review(s) available for lamivudine and brl 42810
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
New nucleoside analogues for chronic hepatitis B.
Topics: 2-Aminopurine; Antiviral Agents; Arabinofuranosyluracil; Chronic Disease; Drug Evaluation, Preclinical; Famciclovir; Hepatitis B; Humans; Lamivudine; Nucleosides; Zalcitabine | 1995 |
New developments in antiviral therapy for chronic hepatitis B infection.
Topics: 2-Aminopurine; Antiviral Agents; Arabinofuranosyluracil; Clinical Trials as Topic; Famciclovir; Hepatitis B; Hepatitis, Chronic; Humans; Interferon-alpha; Lamivudine; Treatment Outcome; Zalcitabine | 1995 |
Treatment of posttransplantation hepatitis B.
Topics: 2-Aminopurine; Antiviral Agents; Famciclovir; Ganciclovir; Hepatitis B; Humans; Lamivudine; Liver Transplantation | 1997 |
Chronic hepatitis B: interferon-monotherapy or combination with nucleoside analogues?
Topics: 2-Aminopurine; Antiviral Agents; Drug Therapy, Combination; Famciclovir; Hepatitis B, Chronic; Humans; Interferon-alpha; Lamivudine; Reverse Transcriptase Inhibitors | 1998 |
[New antiviral agents in the treatment of chronic hepatitis B and C].
Topics: 2-Aminopurine; Antimetabolites; Antiviral Agents; Clinical Trials as Topic; Famciclovir; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Lamivudine; Prodrugs; Reverse Transcriptase Inhibitors; Ribavirin | 1998 |
Experience with lamivudine against hepatitis B virus.
Topics: 2-Aminopurine; Acyclovir; Antiviral Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Famciclovir; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunocompromised Host; Interferons; Lamivudine; Liver Transplantation; Mutation; Nucleosides; Reverse Transcriptase Inhibitors | 1997 |
Treatment of chronic viral hepatitis.
Topics: 2-Aminopurine; Animals; Antimetabolites; Antiviral Agents; Carcinoma, Hepatocellular; Disease Models, Animal; Drug Therapy, Combination; Ducks; Famciclovir; Female; Hepatitis B, Chronic; Hepatitis C, Chronic; Hepatitis, Animal; Humans; Immunologic Factors; Interferon-alpha; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Male; Marmota; Poultry Diseases; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Tumor Cells, Cultured | 1998 |
[New management of hepatitis B virus].
Topics: 2-Aminopurine; Adrenal Cortex Hormones; Antiviral Agents; Famciclovir; Germanium; Hepatitis B; Humans; Immunologic Factors; Interferons; Interleukin-12; Lamivudine; Organometallic Compounds; Propionates; Reverse Transcriptase Inhibitors; Thymosin | 1999 |
New antiviral agents for the therapy of chronic hepatitis B virus infection.
Topics: 2-Aminopurine; Acyclovir; Antiviral Agents; Clinical Trials as Topic; Drug Resistance, Microbial; Drug Therapy, Combination; Famciclovir; Hepatitis B, Chronic; Humans; Lamivudine; Virus Replication | 1999 |
Antiviral agents for non-human immunodeficiency virus infections.
Topics: 2-Aminopurine; Acetamides; Acyclovir; Amantadine; Antiviral Agents; Cidofovir; Cytosine; Drug Resistance, Microbial; Drugs, Investigational; Enzyme Inhibitors; Famciclovir; Foscarnet; Ganciclovir; Guanidines; Guanine; Humans; Interferons; Lamivudine; Neuraminidase; Organophosphonates; Organophosphorus Compounds; Oseltamivir; Pyrans; Ribavirin; Sialic Acids; Valacyclovir; Valine; Virus Diseases; Zanamivir | 1999 |
Preclinical aspects of lamivudine and famciclovir against hepatitis B virus.
Topics: 2-Aminopurine; Antiviral Agents; Famciclovir; Hepatitis B; Hepatitis B virus; Humans; Lamivudine | 1999 |
Current limitations to nucleoside analogue therapy for chronic hepatitis B virus infection in the liver transplant and non-transplant settings.
Topics: 2-Aminopurine; Adenine; Antiviral Agents; DNA, Viral; Famciclovir; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Transplantation; Organophosphonates; Treatment Outcome | 2000 |
Antiviral therapy of HBV- and HCV-induced liver cirrhosis.
Topics: 2-Aminopurine; Antiviral Agents; Clinical Trials as Topic; Famciclovir; Female; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferon-alpha; Lamivudine; Liver Cirrhosis; Male; Prognosis; Reverse Transcriptase Inhibitors; Survival Rate; Thymalfasin; Thymosin; Treatment Outcome | 2000 |
Posttransplantation: emerging and future therapies.
Topics: 2-Aminopurine; Antiviral Agents; Drug Therapy, Combination; Famciclovir; Ganciclovir; Hepatitis B; Humans; Lamivudine; Liver Transplantation; Nucleosides; Postoperative Care; Risk Factors; Secondary Prevention; Survival Analysis | 2000 |
Nucleoside analogues in the treatment of chronic hepatitis B.
Topics: 2-Aminopurine; Adenine; Antiviral Agents; Deoxycytidine; Emtricitabine; Famciclovir; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Nucleosides; Organophosphonates | 2000 |
Antiviral therapy to prevent and treat hepatitis B virus infection in hepatic allografts.
Topics: 2-Aminopurine; Antiviral Agents; Drug Combinations; Drug Resistance, Microbial; Famciclovir; Ganciclovir; Hepatitis B; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver Transplantation; Survival Rate; Transplantation, Homologous | 2000 |
Nucleoside analogues and other investigational modalities for the treatment of chronic hepatitis B.
Topics: 2-Aminopurine; Animals; Antiviral Agents; Arabinofuranosyluracil; Clinical Trials as Topic; Combined Modality Therapy; Dideoxynucleosides; Famciclovir; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Transplantation; Reverse Transcriptase Inhibitors; Ribavirin; Vidarabine | 1996 |
Hepatitis B infection in China.
Topics: 2-Aminopurine; Adenine; Antiviral Agents; China; Deoxycytidine; DNA, Viral; Drug Therapy, Combination; Drugs, Chinese Herbal; Emtricitabine; Famciclovir; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon-alpha; Lamivudine; Organophosphonates; Thymosin | 2001 |
Resistance of hepatitis B virus to antiviral drugs: current aspects and directions for future investigation.
Topics: 2-Aminopurine; Adenine; Amino Acid Sequence; Animals; Anti-HIV Agents; Antimetabolites; Antiviral Agents; Biological Availability; Cell Line; Clinical Trials as Topic; DNA Replication; DNA-Directed DNA Polymerase; DNA, Viral; Drug Design; Drug Evaluation, Preclinical; Drug Resistance, Multiple; Drug Resistance, Viral; Drug Therapy, Combination; Enzyme Inhibitors; Famciclovir; Gene Products, pol; Hepatitis B; Hepatitis B virus; Hepatitis Viruses; Hepatitis, Animal; HIV; Humans; Lamivudine; Models, Animal; Molecular Sequence Data; Molecular Structure; Nucleosides; Organophosphonates; Sequence Alignment; Sequence Homology, Amino Acid; Species Specificity; Virus Replication | 2001 |
Nucleoside analogues for chronic hepatitis B.
Topics: 2-Aminopurine; Adenine; Antiviral Agents; Famciclovir; Ganciclovir; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Organophosphonates; Reverse Transcriptase Inhibitors | 2001 |
How will we use the new antiviral agents for hepatitis B?
Topics: 2-Aminopurine; Adenine; Alanine Transaminase; Antiviral Agents; Drug Resistance; Drug Therapy, Combination; Famciclovir; Ganciclovir; Gene Products, pol; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon-alpha; Lamivudine; Mutation; Organophosphonates; Practice Guidelines as Topic | 2002 |
Therapeutic advances in the management of hepatitis B and hepatitis C.
Topics: 2-Aminopurine; Antiviral Agents; Drug Therapy, Combination; Famciclovir; Hepatitis B; Hepatitis C; Humans; Interferon-alpha; Lamivudine; Ribavirin | 2001 |
Nucleoside analogues for chronic hepatitis B: antiviral efficacy and viral resistance.
Topics: 2-Aminopurine; Antiviral Agents; Cross Reactions; Drug Resistance, Viral; Famciclovir; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Nucleosides; Reverse Transcriptase Inhibitors; Virus Replication | 2002 |
Thymosin in the treatment of HBeAg-negative chronic hepatitis B.
Topics: 2-Aminopurine; Antiviral Agents; Drug Therapy, Combination; Famciclovir; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Interferons; Lamivudine; Reverse Transcriptase Inhibitors; Thymosin | 2003 |
Current pharmacotherapy for the treatment of chronic hepatitis B.
Topics: 2-Aminopurine; Adenine; Antiviral Agents; Clinical Trials as Topic; Famciclovir; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferons; Lamivudine; Liver Transplantation; Mutation; Nucleosides; Organophosphonates | 2003 |
Treatment of recurrence of hepatitis B in transplant patients.
Topics: 2-Aminopurine; Antiviral Agents; Drug Resistance, Microbial; Famciclovir; Hepatitis B; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Postoperative Care; Reverse Transcriptase Inhibitors; Secondary Prevention | 2003 |
[New approaches in the treatment of hepatitis B].
Topics: 2-Aminopurine; Adenine; Antiviral Agents; Arabinofuranosyluracil; Carcinoma, Hepatocellular; Contraindications; Deoxycytidine; Emtricitabine; Famciclovir; Guanine; Hepatitis B, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Liver Neoplasms; Organophosphonates; Organophosphorus Compounds; Polyethylene Glycols; Prodrugs; Prognosis; Recombinant Proteins; Tenofovir; Zalcitabine | 2004 |
11 trial(s) available for lamivudine and brl 42810
Article | Year |
---|---|
Combination therapy with lamivudine and famciclovir for chronic hepatitis B-infected Chinese patients: a viral dynamics study.
Topics: 2-Aminopurine; Adolescent; Adult; Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Famciclovir; Female; Follow-Up Studies; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged | 2000 |
Lamivudine as first- and second-line treatment of hepatitis B infection after liver transplantation.
Topics: 2-Aminopurine; Anti-HIV Agents; Antiviral Agents; Famciclovir; Hepatitis B; Hepatitis B virus; HIV; Humans; Lamivudine; Liver; Liver Transplantation; Prospective Studies; Reverse Transcriptase Inhibitors | 2000 |
[Prevention and treatment of HBV reinfection following liver transplantation].
Topics: 2-Aminopurine; Adult; Antiviral Agents; Biopsy; DNA, Viral; Drug Combinations; Famciclovir; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Postoperative Care; Preoperative Care; Recurrence | 2002 |
Comparison of the efficacy of lamivudine and famciclovir in Asian patients with chronic hepatitis B: results of 24 weeks of therapy.
Topics: 2-Aminopurine; Adolescent; Adult; Antiviral Agents; China; DNA, Viral; Famciclovir; Female; Hepatitis B Antibodies; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Treatment Outcome | 2002 |
Comparison of different treatment combinations for chronic hepatitis B infection.
Topics: 2-Aminopurine; Adolescent; Adult; Aged; Antiviral Agents; DNA, Viral; Drug Administration Schedule; Drug Therapy, Combination; Famciclovir; Female; Hepatitis B Vaccines; Hepatitis B virus; Hepatitis B, Chronic; Humans; Injections, Intramuscular; Injections, Subcutaneous; Interferon-alpha; Lamivudine; Male; Middle Aged; Treatment Outcome | 2002 |
Lamivudine and famciclovir combination therapy with or without addition of interferon-alpha-2b for HBeAg-positive chronic hepatitis B: a pilot study.
Topics: 2-Aminopurine; Adult; Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Famciclovir; Female; Hepatitis B; Hepatitis B e Antigens; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Male; Middle Aged; Pilot Projects; Recombinant Proteins | 2002 |
Viral dynamics in chronic hepatitis B patients treated with lamivudine, lamivudine-famciclovir or lamivudine-ganciclovir.
Topics: 2-Aminopurine; Adult; Antiviral Agents; Drug Therapy, Combination; Famciclovir; Female; Ganciclovir; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Models, Theoretical; Reverse Transcriptase Inhibitors; Virus Replication | 2002 |
[Famciclovir treatment of patients with chronic hepatitis B virus infection].
Topics: 2-Aminopurine; Adolescent; Aged; Antiviral Agents; Famciclovir; Female; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon-alpha; Lamivudine; Male; Middle Aged; Treatment Outcome | 2002 |
Combination therapy with lamivudine and famciclovir for chronic hepatitis B infection.
Topics: 2-Aminopurine; Adult; Aged; Antiviral Agents; DNA, Viral; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Famciclovir; Female; Follow-Up Studies; Hepatitis B, Chronic; Humans; Lamivudine; Liver Function Tests; Male; Middle Aged; Pilot Projects; Risk Assessment; Severity of Illness Index; Treatment Outcome; Viral Load | 2004 |
Sequential combination therapy of HBe antigen-negative/virus-DNA-positive chronic hepatitis B with famciclovir or lamivudine and interferon-alpha-2a.
Topics: 2-Aminopurine; Administration, Oral; Adolescent; Adult; Aged; Alanine Transaminase; Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Famciclovir; Female; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Injections, Subcutaneous; Interferon alpha-2; Interferon-alpha; Lamivudine; Male; Middle Aged; Mutation; Recombinant Proteins; Treatment Outcome; Viral Load; Viremia | 2004 |
A prospective study on chemotherapy-induced hepatitis B virus reactivation in chronic HBs Ag carriers with hematologic malignancies and pre-emptive therapy with nucleoside analogues.
Topics: 2-Aminopurine; Adult; Aged; Antineoplastic Agents; Antiviral Agents; Chronic Disease; Famciclovir; Female; Hematologic Neoplasms; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Nucleosides; Pilot Projects; Prospective Studies; Virus Activation | 2006 |
60 other study(ies) available for lamivudine and brl 42810
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Antiviral effect of orally administered (-)-beta-D-2-aminopurine dioxolane in woodchucks with chronic woodchuck hepatitis virus infection.
Topics: Administration, Oral; Animals; Antiviral Agents; Dioxolanes; DNA, Viral; Dose-Response Relationship, Drug; Guanine; Half-Life; Hepatitis B Virus, Woodchuck; Hepatitis B, Chronic; Injections, Intravenous; Marmota; Prodrugs; Purines; Tissue Distribution | 2007 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Anti-BK virus activity of nucleoside analogs.
Topics: Adenine; BK Virus; Esters; Fatty Acids; Humans; Microbial Sensitivity Tests; Nucleosides; Organophosphonates; Virus Replication | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Hepatitis B virus infection and liver transplantation.
Topics: 2-Aminopurine; Antiviral Agents; Famciclovir; Hepatitis B; Hepatitis B Vaccines; Humans; Immunization, Passive; Immunoglobulins; Immunosuppression Therapy; Interferon-gamma; Lamivudine; Liver Transplantation; Patient Selection | 1997 |
Drugs for non-HIV viral infections.
Topics: 2-Aminopurine; Abnormalities, Drug-Induced; Acyclovir; Amantadine; Antiviral Agents; Cidofovir; Contraindications; Cytosine; Drug Resistance, Microbial; Eye Infections, Viral; Famciclovir; Foscarnet; Ganciclovir; Guanine; Humans; Interferon-alpha; Kidney Diseases; Lamivudine; Organophosphonates; Organophosphorus Compounds; Prodrugs; Ribavirin; Rimantadine; Trifluridine; Valacyclovir; Valine; Virus Diseases | 1997 |
Hepatitis B virus mutants associated with 3TC and famciclovir administration are replication defective.
Topics: 2-Aminopurine; Amino Acid Sequence; Antiviral Agents; Blotting, Northern; Carcinoma, Hepatocellular; Cell Line; Famciclovir; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Hydroxyurea; Lamivudine; Liver Neoplasms; Molecular Sequence Data; Mutation; Nucleic Acid Synthesis Inhibitors; Reverse Transcriptase Inhibitors; Transfection; Tumor Cells, Cultured; Virus Replication | 1998 |
Postliver transplant allograft reinfection with a lamivudine-resistant strain of hepatitis B virus: long-term follow-up.
Topics: 2-Aminopurine; Adult; Antiviral Agents; Drug Resistance, Microbial; Famciclovir; Female; Follow-Up Studies; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Recurrence; Time Factors | 1998 |
[Prevention of hepatitis B--analysis of cost-effectiveness after liver transplantation].
Topics: 2-Aminopurine; Adult; Antiviral Agents; Cost-Benefit Analysis; Famciclovir; Female; Hepatitis B; Humans; Lamivudine; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Recurrence | 1997 |
Efficacy of famciclovir treatment in chronic hepatitis B patients with different mutations at position 552 of the DNA polymerase gene.
Topics: 2-Aminopurine; Alanine Transaminase; Antiviral Agents; DNA-Directed DNA Polymerase; DNA, Viral; Famciclovir; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Point Mutation; Prodrugs | 1998 |
Advances in the treatment of viral hepatitis.
Topics: 2-Aminopurine; Antiviral Agents; Famciclovir; Hepatitis B; Hepatitis C; Hepatitis, Viral, Human; Humans; Interferon-alpha; Lamivudine | 1998 |
The sequential occurrence of viral mutations in a liver transplant recipient re-infected with hepatitis B: hepatitis B immune globulin escape, famciclovir non-response, followed by lamivudine resistance resulting in graft loss.
Topics: 2-Aminopurine; Amino Acid Sequence; Antiviral Agents; DNA-Directed DNA Polymerase; DNA, Viral; Drug Resistance; Famciclovir; Hepatitis B; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver; Liver Transplantation; Male; Middle Aged; Molecular Sequence Data; Mutation; Recurrence; Viral Proteins | 1998 |
[Drug therapy of chronic hepatitis B].
Topics: 2-Aminopurine; Antiviral Agents; Famciclovir; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon-alpha; Lamivudine; Reverse Transcriptase Inhibitors; Treatment Outcome; Virus Replication | 1998 |
Treatment of chronic hepatitis B virus infection: an Asia-Pacific perspective.
Topics: 2-Aminopurine; Adjuvants, Immunologic; Animals; Antiviral Agents; Asia; Drug Therapy, Combination; Famciclovir; Hepatitis B Vaccines; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Pacific Islands; Vaccines, DNA | 1999 |
Mutational pattern of hepatitis B virus on sequential therapy with famciclovir and lamivudine in patients with hepatitis B virus reinfection occurring under HBIg immunoglobulin after liver transplantation.
Topics: 2-Aminopurine; Adult; Amino Acid Substitution; Antiviral Agents; DNA Primers; DNA-Directed DNA Polymerase; Famciclovir; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Methionine; Middle Aged; Point Mutation; Polymerase Chain Reaction; Prodrugs; Recurrence; Risk Factors; Valine | 1999 |
Is nucleoside analogue monotherapy sufficient for treatment of HBV infection? Lessons from HIV.
Topics: 2-Aminopurine; Anti-HIV Agents; Antiviral Agents; Deoxyguanosine; Famciclovir; Hepatitis B; HIV Infections; Humans; Lamivudine | 1999 |
Disappearance of hepatitis B virus core deletion mutants and successful combined kidney/liver transplantation in a patient treated with lamivudine.
Topics: 2-Aminopurine; Antiviral Agents; DNA, Viral; Famciclovir; Follow-Up Studies; Genetic Variation; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunosuppressive Agents; Kidney Transplantation; Lamivudine; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Mutation; Renal Dialysis; Sequence Deletion | 1999 |
Cell-mediated immune responses and loss of hepatitis B e-antigen (HBeAg) during successful lamivudine and famciclovir combination therapy for chronic replicating hepatitis B virus infection.
Topics: 2-Aminopurine; Aged; Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Famciclovir; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunity, Cellular; Lamivudine; Male; Treatment Outcome; Virus Replication | 1999 |
Selection of multiresistant hepatitis B virus during sequential nucleoside-analogue therapy.
Topics: 2-Aminopurine; Antiviral Agents; DNA-Directed DNA Polymerase; DNA, Viral; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Famciclovir; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Mutation; Reverse Transcriptase Inhibitors; Viral Load | 2000 |
Persistence of viral replication after anti-HBe seroconversion during antiviral therapy for chronic hepatitis B.
Topics: 2-Aminopurine; Antibodies, Viral; Antiviral Agents; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Famciclovir; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon-alpha; Lamivudine; Virus Replication | 2000 |
Enhanced antiviral benefit of combination therapy with lamivudine and famciclovir against WHV replication in chronic WHV carrier woodchucks.
Topics: 2-Aminopurine; Animals; Antiviral Agents; Carrier State; Disease Models, Animal; Drug Therapy, Combination; Famciclovir; Hepatitis B Virus, Woodchuck; Hepatitis B, Chronic; Lamivudine; Marmota; Prodrugs; Reverse Transcriptase Inhibitors; Viremia; Virus Replication | 2000 |
[Dynamic changes of hepatitis B virus during treatment with lamivudine versus lamivudine plus famciclovir].
Topics: 2-Aminopurine; Adolescent; Adult; Antiviral Agents; Drug Therapy, Combination; Famciclovir; Female; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Virus Replication | 2000 |
Combination chemotherapy for hepatitis B virus: the final solution?
Topics: 2-Aminopurine; Antiviral Agents; DNA, Viral; Drug Resistance; Drug Therapy, Combination; Famciclovir; Hepatitis B, Chronic; Humans; Lamivudine | 2000 |
Drugs for non-HIV viral infections.
Topics: 2-Aminopurine; Acetamides; Acyclovir; Aged; Amantadine; Animals; Anti-HIV Agents; Antiviral Agents; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Enzyme Inhibitors; Famciclovir; Ganciclovir; Guanidines; Guanine; Herpes Simplex; Herpes Zoster; History, 18th Century; HIV Infections; Humans; Injections, Intravenous; Interferon-alpha; Lamivudine; Neuraminidase; Oseltamivir; Pyrans; Rats; Ribavirin; Sialic Acids; Teratogens; Valacyclovir; Valine; Zanamivir | 1999 |
Early detection of viral resistance by determination of hepatitis B virus polymerase mutations in patients treated by lamivudine for chronic hepatitis B.
Topics: 2-Aminopurine; Adolescent; Adult; Aged; Aged, 80 and over; DNA, Viral; Drug Resistance, Microbial; Drug Therapy, Combination; Famciclovir; Female; Gene Products, pol; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon-alpha; Lamivudine; Male; Middle Aged; Mutation; Recombinant Proteins; Retreatment; Reverse Transcriptase Inhibitors | 2000 |
[Therapy of recurrent hepatitis B infection after liver transplantation. A retrospective analysis of 200 liver transplantations based on hepatitis B associated liver diseases].
Topics: 2-Aminopurine; Adult; Antiviral Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Famciclovir; Female; Hepatitis B, Chronic; Humans; Immunization, Passive; Interferon alpha-2; Interferon-alpha; Lamivudine; Liver Transplantation; Male; Middle Aged; Recombinant Proteins; Recurrence; Retrospective Studies; Survival Rate; Treatment Outcome | 2000 |
Antiviral combination therapy for lamivudine-resistant hepatitis B reinfection after liver transplantation.
Topics: 2-Aminopurine; Alanine Transaminase; Antiviral Agents; DNA, Viral; Drug Resistance, Microbial; Drug Therapy, Combination; Famciclovir; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Liver Transplantation; Middle Aged; Postoperative Complications; Recombinant Proteins; Recurrence; Retrospective Studies; Time Factors; Virus Replication | 2000 |
Lamivudine improves the prognosis of patients with hepatitis B after liver transplantation.
Topics: 2-Aminopurine; Antiviral Agents; Famciclovir; Follow-Up Studies; Hepatitis B; Humans; Lamivudine; Liver Transplantation; Postoperative Complications; Prodrugs; Prognosis; Recurrence; Retrospective Studies; Time Factors; Treatment Failure; Treatment Outcome | 2000 |
Comparison of famciclovir and lamivudine in the long-term treatment of hepatitis B infection after liver transplantation.
Topics: 2-Aminopurine; Adult; Aged; Antiviral Agents; DNA, Viral; Famciclovir; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Transplantation; Male; Middle Aged; Multivariate Analysis; Time Factors | 2001 |
[Current treatment of hepatitis B].
Topics: 2-Aminopurine; Adenine; Anti-Inflammatory Agents; Antiviral Agents; DNA Replication; Famciclovir; Forecasting; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon-alpha; Lamivudine; Organophosphonates; Prednisone; Prognosis; Reverse Transcriptase Inhibitors; Time Factors; Virus Replication | 2001 |
[Laboratory diagnosis of hepatitis B].
Topics: 2-Aminopurine; Acute Disease; Antiviral Agents; DNA Replication; DNA, Viral; Drug Resistance; Famciclovir; Genetic Variation; Genotype; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunohistochemistry; Lamivudine; Virus Replication | 2001 |
Cross-resistance testing of antihepadnaviral compounds using novel recombinant baculoviruses which encode drug-resistant strains of hepatitis B virus.
Topics: 2-Aminopurine; Antiviral Agents; Baculoviridae; Cells, Cultured; DNA, Viral; Drug Resistance, Microbial; Famciclovir; Genome, Viral; Hepadnaviridae; Hepatitis B virus; Lamivudine; Microbial Sensitivity Tests; Mutagenesis | 2001 |
Severe clinical course of de novo hepatitis B infection after liver transplantation.
Topics: 2-Aminopurine; Adult; Antiviral Agents; Famciclovir; Fatal Outcome; Female; Hepatitis B; Humans; Lamivudine; Liver Transplantation; Middle Aged; Postoperative Complications; Recurrence; Reoperation; Retrospective Studies; Treatment Outcome | 2001 |
Efficacy of lamivudine for the treatment of hepatitis B virus infection after liver transplantation in children.
Topics: 2-Aminopurine; Adolescent; Alanine Transaminase; Antiviral Agents; Child; Child, Preschool; Cystic Fibrosis; DNA, Viral; Famciclovir; Female; Hepatitis A; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Hyperoxaluria; Lamivudine; Liver Failure; Liver Transplantation; Living Donors; Male; Postoperative Complications; Retrospective Studies; Time Factors | 2001 |
[Experimental study on the effect of combination therapy with lamivudine and famciclovir against duck hepatitis B virus in vivo].
Topics: 2-Aminopurine; Animals; Antiviral Agents; Disease Models, Animal; DNA, Viral; Drug Therapy, Combination; Ducks; Famciclovir; Hepadnaviridae Infections; Hepatitis B Virus, Duck; Hepatitis, Viral, Animal; Lamivudine; Microbial Sensitivity Tests | 2001 |
Analysis of hepatitis B viral load decline under potent therapy: complex decay profiles observed.
Topics: 2-Aminopurine; Antiviral Agents; Computer Systems; DNA, Viral; Drug Therapy, Combination; Famciclovir; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Polymerase Chain Reaction; Reproducibility of Results; Reverse Transcriptase Inhibitors; Sensitivity and Specificity; Time Factors; Viral Load | 2001 |
Preoperative antiviral treatment and postoperative prophylaxis in HBV-DNA positive patients undergoing liver transplantation.
Topics: 2-Aminopurine; Adult; Antiviral Agents; DNA, Viral; Famciclovir; Female; Hepatitis B; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Recurrence; Retrospective Studies | 2001 |
Failure of combination therapy with lamivudine and famciclovir following lamivudine monotherapy for hepatitis B virus infection in patients coinfected with human immunodeficiency virus-1.
Topics: 2-Aminopurine; Antiviral Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Famciclovir; Hepatitis B; Hepatitis B virus; HIV Infections; HIV-1; Humans; Lamivudine; Male; Mutation; Treatment Failure | 2001 |
Efficacy of famciclovir in the treatment of lamivudine resistance related to an atypical hepatitis B virus mutant.
Topics: 2-Aminopurine; Adult; DNA, Viral; Drug Resistance, Microbial; Famciclovir; Female; Hepatitis B; Hepatitis B virus; Humans; Kidney Failure, Chronic; Kidney Transplantation; Lamivudine; Mutation; Postoperative Complications | 2002 |
Drugs for non-HIV viral infections.
Topics: 2-Aminopurine; Acyclovir; Administration, Oral; Administration, Topical; Amantadine; Animals; Antiviral Agents; Cidofovir; Cytosine; Famciclovir; Foscarnet; Guanine; Herpesviridae Infections; Humans; Influenza, Human; Injections, Intravenous; Lamivudine; Organophosphonates; Organophosphorus Compounds; Rats; Ribavirin; Rimantadine; Thionucleotides; Trifluridine; Valacyclovir; Valine | 2002 |
Combination therapy for hepatitis B.
Topics: 2-Aminopurine; Antiviral Agents; Drug Therapy, Combination; Famciclovir; Forecasting; Hepatitis B, Chronic; Humans; Interferon-alpha; Lamivudine | 2002 |
Seroconversion after the addition of famciclovir therapy in a child with hepatitis B virus infection after liver transplantation who developed lamivudine resistance.
Topics: 2-Aminopurine; Alanine Transaminase; Antiviral Agents; Child, Preschool; DNA, Viral; Drug Resistance, Viral; Famciclovir; Hepatitis B; Humans; Lamivudine; Liver Transplantation; Male | 2002 |
Successful antiviral treatment for fulminant reactivated hepatitis B after autologous stem cell transplantation and prophylaxis during subsequent allogeneic stem cell transplantation.
Topics: 2-Aminopurine; Adult; Antiviral Agents; Famciclovir; Female; Hematopoietic Stem Cell Transplantation; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Transplantation, Autologous; Transplantation, Homologous; Virus Activation | 2002 |
Fatal hepatitis B reactivation following discontinuation of nucleoside analogues for chronic hepatitis B.
Topics: 2-Aminopurine; Adult; Aged; Alanine Transaminase; Antiviral Agents; Bilirubin; DNA, Viral; Drug Resistance, Viral; Famciclovir; Fatal Outcome; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Mutation; Recurrence; Virus Activation | 2002 |
The use of antiviral monotherapy and combination therapy for patients with hepatitis B virus infection after liver transplantation.
Topics: 2-Aminopurine; Antiviral Agents; Drug Therapy, Combination; Famciclovir; Hepatitis B; Hepatitis B Surface Antigens; Humans; Lamivudine; Liver Function Tests; Liver Transplantation; Recurrence | 2002 |
Treatment of recurrent hepatitis B infection in liver transplant recipients.
Topics: 2-Aminopurine; Adenine; Antiviral Agents; Famciclovir; Hepatitis B; Humans; Interferon-alpha; Lamivudine; Liver Transplantation; Organophosphonates; Recurrence; Reverse Transcriptase Inhibitors | 2002 |
Lamivudine and Famciclovir resistant hepatitis B virus associated with fatal hepatic failure.
Topics: 2-Aminopurine; Adult; Antiviral Agents; Drug Resistance, Viral; Drug Therapy, Combination; Famciclovir; Fatal Outcome; Female; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Failure; Reverse Transcriptase Inhibitors | 2003 |
[Treatment of patients with chronic hepatitis B virus infect ion with lamivudine combined with famciclovir].
Topics: 2-Aminopurine; Adolescent; Adult; Aged; Antiviral Agents; Child; Drug Therapy, Combination; Famciclovir; Female; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged | 2003 |
The hepatitis B virus polymerase mutation rtV173L is selected during lamivudine therapy and enhances viral replication in vitro.
Topics: 2-Aminopurine; Amino Acid Sequence; Antiviral Agents; Drug Resistance, Viral; Famciclovir; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Microbial Sensitivity Tests; Models, Molecular; Molecular Sequence Data; Mutation; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Selection, Genetic; Virus Replication | 2003 |
Prophylaxis and treatment of hepatitis B virus reinfection following liver transplantation.
Topics: 2-Aminopurine; Adult; Antiviral Agents; DNA, Viral; Dose-Response Relationship, Drug; Drug Therapy, Combination; Famciclovir; Hepatitis B; Hepatitis B Core Antigens; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Liver Transplantation; Male; Postoperative Complications; Reverse Transcriptase Inhibitors; Secondary Prevention | 2002 |
Detection of hepatitis B virus variants resistant to lamivudine and famciclovir among randomly selected chronic carriers from Spain.
Topics: 2-Aminopurine; Amino Acid Sequence; Antiviral Agents; Diagnostic Tests, Routine; DNA Mutational Analysis; DNA, Viral; Drug Resistance, Multiple, Viral; Famciclovir; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Microbial Sensitivity Tests; Molecular Sequence Data; Point Mutation; Retrospective Studies; RNA-Directed DNA Polymerase; Spain | 2004 |
Improved outcome of chronic hepatitis B after heart transplantation by long-term antiviral therapy.
Topics: 2-Aminopurine; Adult; Aged; Antiviral Agents; Carcinoma, Hepatocellular; Famciclovir; Female; Heart Transplantation; Hepatitis B, Chronic; Humans; Immunosuppressive Agents; Lamivudine; Liver Neoplasms; Male; Middle Aged | 2006 |
Lamivudine and famciclovir treatment in HIV patients with acute hepatitis B virus infection and hepatitis B reactivation.
Topics: 2-Aminopurine; Alanine Transaminase; Antiviral Agents; Aspartate Aminotransferases; Famciclovir; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Male; Reverse Transcriptase Inhibitors; Virus Activation | 2007 |
A decline in hepatitis B virus surface antigen (hbsag) predicts clearance, but does not correlate with quantitative hbeag or HBV DNA levels.
Topics: 2-Aminopurine; Antiviral Agents; DNA, Viral; Famciclovir; Female; Heart Transplantation; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Liver Transplantation; Male; Predictive Value of Tests; Treatment Outcome | 2008 |